SAVA
Cassava Sciences, Inc.NASDAQHealthcare$1.96-1.76%ClosedMarket Cap: $94.4M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
1.09
P/S
0.00
EV/EBITDA
0.15
DCF Value
$1.15
FCF Yield
-109.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-97.9%
ROA
-76.9%
ROIC
-128.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-13.6M | $-12.5M | $-0.26 | — |
| FY 2025 | $0.00 | -Infinity% | $-95.4M | $-91.0M | $-1.88 | — |
| Q3 2025 | $0.00 | -Infinity% | $-11.9M | $-10.8M | $-0.22 | — |
| Q2 2025 | $0.00 | -Infinity% | $-45.4M | $-44.2M | $-0.92 | — |
| Q1 2025 | $0.00 | -Infinity% | $-24.6M | $-23.4M | $-0.48 | — |
| Q4 2024 | $0.00 | -Infinity% | $-29.5M | $-27.6M | $-0.57 | — |
| FY 2024 | $0.00 | NaN% | $-141.4M | $-24.3M | $-0.52 | — |
| Q3 2024 | $0.00 | -Infinity% | $-30.6M | $-27.9M | $-0.58 | — |
| Q2 2024 | $0.00 | -Infinity% | $-61.4M | $6.2M | $0.13 | — |
| Q1 2024 | $0.00 | -Infinity% | $-19.9M | $25.0M | $-0.43 | — |
| Q4 2023 | $0.00 | -Infinity% | $-22.8M | $-20.9M | $-0.50 | — |
| FY 2023 | $0.00 | -Infinity% | $-106.0M | $-97.2M | $-2.32 | — |